Peripheral injections of melanin-concentrating hormone receptor 1 antagonist S38151 decrease food intake and body weight in rodent obesity models

The compound S38151 is a nanomolar antagonist that acts at the melanin-concentrating hormone receptor 1 (MCH1). S38151 is more stable than its purely peptide counterpart, essentially because of the blockade of its N-terminus. Therefore, , its action on various models of obesity was studied. Acute in...

Full description

Bibliographic Details
Main Authors: Odile eDella-Zuana, Valerie eAudinot, Viviane eLevenez, Alain eKtorza, Françoise ePresse, Jean-Louis eNahon, Jean Albert Boutin
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-12-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00160/full
_version_ 1819139217860591616
author Odile eDella-Zuana
Valerie eAudinot
Viviane eLevenez
Alain eKtorza
Françoise ePresse
Jean-Louis eNahon
Jean Albert Boutin
author_facet Odile eDella-Zuana
Valerie eAudinot
Viviane eLevenez
Alain eKtorza
Françoise ePresse
Jean-Louis eNahon
Jean Albert Boutin
author_sort Odile eDella-Zuana
collection DOAJ
description The compound S38151 is a nanomolar antagonist that acts at the melanin-concentrating hormone receptor 1 (MCH1). S38151 is more stable than its purely peptide counterpart, essentially because of the blockade of its N-terminus. Therefore, , its action on various models of obesity was studied. Acute intracerebroventricular (i.c.v.) administration of S38151 in wild-type rats counteracted the effect of the stable precursor of melanin-concentrating hormone (MCH), NEI-MCH, in a dose-dependent manner (from 0.5 to 50 nmol/kg). In genetically obese Zucker fa/fa rats, daily i.c.v. administration of S38151 induced dose-dependent (5, 10, and 20 nmol/kg) inhibition of food intake, water intake, and body weight gain, as well as increased motility (maximal effect observed at 20 nmol/kg). In Zucker fa/fa rats, intraperitoneal injection of S38151 (30 mg/kg) induced complete inhibition of food consumption within 1 h. Daily intraperitoneal injection of S38151 (10 and 30 mg/kg) into genetically obese ob/ob mice or diet-induced obese mice is able to limit body weight gain. Furthermore, S38151 administration (10 and 30 mg/kg) does not affect food intake, water intake, or body weight gain in MCHR1-deleted mice, demonstrating that its effects are linked to its interaction with MCH1. These results validate MCH1 as a target of interest in obesity. S38151 cannot progress to the clinical phase because it is still too poorly stable in vivo.
first_indexed 2024-12-22T11:19:10Z
format Article
id doaj.art-adf31110f4804ea0bc7005a56c3b4716
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-22T11:19:10Z
publishDate 2012-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-adf31110f4804ea0bc7005a56c3b47162022-12-21T18:27:55ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922012-12-01310.3389/fendo.2012.0016036840Peripheral injections of melanin-concentrating hormone receptor 1 antagonist S38151 decrease food intake and body weight in rodent obesity modelsOdile eDella-Zuana0Valerie eAudinot1Viviane eLevenez2Alain eKtorza3Françoise ePresse4Jean-Louis eNahon5Jean Albert Boutin6Institut de Recherches SERVIERInstitut de Recherches SERVIERInstitut de Recherches SERVIERInstitut de Recherches SERVIERCNRSCNRSInstitut de Recherches SERVIERThe compound S38151 is a nanomolar antagonist that acts at the melanin-concentrating hormone receptor 1 (MCH1). S38151 is more stable than its purely peptide counterpart, essentially because of the blockade of its N-terminus. Therefore, , its action on various models of obesity was studied. Acute intracerebroventricular (i.c.v.) administration of S38151 in wild-type rats counteracted the effect of the stable precursor of melanin-concentrating hormone (MCH), NEI-MCH, in a dose-dependent manner (from 0.5 to 50 nmol/kg). In genetically obese Zucker fa/fa rats, daily i.c.v. administration of S38151 induced dose-dependent (5, 10, and 20 nmol/kg) inhibition of food intake, water intake, and body weight gain, as well as increased motility (maximal effect observed at 20 nmol/kg). In Zucker fa/fa rats, intraperitoneal injection of S38151 (30 mg/kg) induced complete inhibition of food consumption within 1 h. Daily intraperitoneal injection of S38151 (10 and 30 mg/kg) into genetically obese ob/ob mice or diet-induced obese mice is able to limit body weight gain. Furthermore, S38151 administration (10 and 30 mg/kg) does not affect food intake, water intake, or body weight gain in MCHR1-deleted mice, demonstrating that its effects are linked to its interaction with MCH1. These results validate MCH1 as a target of interest in obesity. S38151 cannot progress to the clinical phase because it is still too poorly stable in vivo.http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00160/fullFeeding BehaviorMiceratreceptorsmelanin-concentrating hormonepeptide antagonists
spellingShingle Odile eDella-Zuana
Valerie eAudinot
Viviane eLevenez
Alain eKtorza
Françoise ePresse
Jean-Louis eNahon
Jean Albert Boutin
Peripheral injections of melanin-concentrating hormone receptor 1 antagonist S38151 decrease food intake and body weight in rodent obesity models
Frontiers in Endocrinology
Feeding Behavior
Mice
rat
receptors
melanin-concentrating hormone
peptide antagonists
title Peripheral injections of melanin-concentrating hormone receptor 1 antagonist S38151 decrease food intake and body weight in rodent obesity models
title_full Peripheral injections of melanin-concentrating hormone receptor 1 antagonist S38151 decrease food intake and body weight in rodent obesity models
title_fullStr Peripheral injections of melanin-concentrating hormone receptor 1 antagonist S38151 decrease food intake and body weight in rodent obesity models
title_full_unstemmed Peripheral injections of melanin-concentrating hormone receptor 1 antagonist S38151 decrease food intake and body weight in rodent obesity models
title_short Peripheral injections of melanin-concentrating hormone receptor 1 antagonist S38151 decrease food intake and body weight in rodent obesity models
title_sort peripheral injections of melanin concentrating hormone receptor 1 antagonist s38151 decrease food intake and body weight in rodent obesity models
topic Feeding Behavior
Mice
rat
receptors
melanin-concentrating hormone
peptide antagonists
url http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00160/full
work_keys_str_mv AT odileedellazuana peripheralinjectionsofmelaninconcentratinghormonereceptor1antagonists38151decreasefoodintakeandbodyweightinrodentobesitymodels
AT valerieeaudinot peripheralinjectionsofmelaninconcentratinghormonereceptor1antagonists38151decreasefoodintakeandbodyweightinrodentobesitymodels
AT vivianeelevenez peripheralinjectionsofmelaninconcentratinghormonereceptor1antagonists38151decreasefoodintakeandbodyweightinrodentobesitymodels
AT alainektorza peripheralinjectionsofmelaninconcentratinghormonereceptor1antagonists38151decreasefoodintakeandbodyweightinrodentobesitymodels
AT francoiseepresse peripheralinjectionsofmelaninconcentratinghormonereceptor1antagonists38151decreasefoodintakeandbodyweightinrodentobesitymodels
AT jeanlouisenahon peripheralinjectionsofmelaninconcentratinghormonereceptor1antagonists38151decreasefoodintakeandbodyweightinrodentobesitymodels
AT jeanalbertboutin peripheralinjectionsofmelaninconcentratinghormonereceptor1antagonists38151decreasefoodintakeandbodyweightinrodentobesitymodels